Sulfonylureas (SUs) are a class of medications used to treat type 2 diabetes mellitus that work by increasing insulin secretion in the pancreas. Second-generation SUs are most often used today because of adverse effects with those in the first generation. However, there is still a risk of hypoglycemia even with the newer medications in the class. The American Diabetes Association encourages a patient-centered approach when initiating pharmacologic therapy. Understanding the pharmacokinetic differences among these medications can allow the consultant pharmacist to make a decision on which medication may be best suited for the patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4140/TCP.n.2015.116. | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!